Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE

POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Standard Dose
1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 212832 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC Form and strength SOLUTION;INTRAVENOUS - 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2024-08-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 212832 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC Form and strength SOLUTION;INTRAVENOUS - 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2024-08-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.